Quick test
Price depends on purchase quantity.
5 or 20 tests per packaging unit.
Please contact us for a customised quote.
AESKU.RAPID SARS-CoV-2 Rapid Test
Easy and safe quick test
The test was developed by the established laboratory of the AESKU.GROUP in Wendelsheim, Germany and offers an excellent sensitivity of 100%, even with swabs containing low viral loads (Ct≤30).
Within 15 minutes you get a reliable and accurate test result using a nasal swab taken at a comfortable 2.5cm within both nostrils.
Complete Kit: Ready for immediate use
The test is supplied as a complete kit. No additional equipment is required.
The simplicity of self-performed sampling has been studied in an external applicability study on 16 to 84 year olds Subjects were certified by the ESfEQA. The test is officially approved for sale to private individuals.
AESKU.RAPID DOWNLOADS
Status 17.02.2021
Gentle application
The test is intended for swabs obtained from the front of the nasal cavity – about 2cm deep from the entrance of the nostril. It has been externally validated for this purpose.
Thanks to its simple application, the test is excellently suited for home, offices, shops, companies, schools, day-care centres, nursing homes and institutions of all kinds.
Perfect for children
The quick test is ideally suited for testing children for the COVID-19 virus. Thanks to the simple and gentle application, children are happy to be tested in this pleasant way (without fear), so the test can be performed more frequently, if needed.
Reliable even with virus mutations
The AESKU.RAPID test uses the Nucleocapsid Protein Antigen.
According to current data, test reliability is not affected by strain mutations.
6 Steps – Quick guide
Specifications
Test kit components (5 or 20 tests per packaging)
ESfEQA Evaluation Study: AESKU SARS-CoV-2 Antigen Rapid Test Performance
| Sensitivity | Specificity | |
| AESKU.RAPID SARS-CoV-2 Rapid Test | 100% Ct Value ≤ 30.0 (95% Cl 95% – 100%) | 98% (95% Cl 95% – 99%) |
ESfEQA Evaluation Study: AESKU SARS-CoV-2 Antigen Rapid Test vs. Realtime PCR
| RT-PCR Positive | RT-PCR Negative | RT-PCR Total | |
| AESKU.RAPID Positive | 105 | 4 | 109 |
| AESKU.RAPID Negative | 4 | 218 | 222 |
| AESKU.RAPID Total | 109 | 222 | 331 |
Positive test results confirm the presence of viral antigens. Negative test results do not completely rule out COVID-19. However, a clinical history of the patient is still necessary to determine the infection status. The samples were tested in parallel with the RT-PCR test of a leading European manufacturer.
How does the antigen quick test work?
An antigen rapid test is a rapid test method that can be used to determine whether a person has an active Covid-19 infection. The test gives a positive or negative result after 15 minutes.
AESKU.RAPID quick test is performed by obtaining a swab in the nose. In this case, the test stick supplied is inserted into each nostril at a depth of 1.5 to 3 cm – in contrast to other tests, in which the stick must be inserted very deep into the nose. As the test can be considered minimally invasive it has been externally validated. The test also provides valid results when the swab is taken from the throat or nose-throat.
Since there are several rapid tests on the market with different quality and accuracy standards, it is not easy to recognize a safe, accurate and reliable test.
AESKU.RAPID quick test is CE-certified. It was developed by the established laboratory of the AESKU.GROUP in Wendelsheim, Germany and offers an excellent sensitivity of 100%. This makes it a reliable tool for combating the COVID-19 pandemic.
The test is reliable even with virus mutations. It uses the Nucleocapsid Protein Antigen and according to current data, its’ reliability is not affected by strain mutations.